The platform offers multiple treatment categories beyond MIC+B12 including semaglutide, tirzepatide, sermorelin, NAD+, metformin, and glutathione - positioning itself as what they describe as a "modern longevity and preventative care platform." What this baseline establishes: a verifiable business entity, a mailing address, published terms and privacy policy, and stated commitments to using state-licensed compounding pharmacies (ReadyRx notes its partner facilities are FDA-registered where applicable
A reconstituted vial of BPC 157 is typically only a few milliliters
Mild and Temporary Reactions Some users may experience minor side effects, such as: Injection site reactions Mild redness, swelling, or irritation at the injection site
However, the employee has full access to the $2,000